Ignite Creation Date:
2024-05-06 @ 7:38 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06087263
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2023-10-12
Brief Title:
Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets KIT Exon 17 18 or 14 Mutation and SDHB Deficient GIST in the Post-imatinib Second-line Setting
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-18
Start Date Type:
ACTUAL
Primary Completion Date:
2032-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2034-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-12
First Submit QC Date:
October 12 2023
Study First Post Date:
2023-10-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-18
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL